Sanne B. Jensen

463 total citations
9 papers, 341 citations indexed

About

Sanne B. Jensen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sanne B. Jensen has authored 9 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Sanne B. Jensen's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and HIV/AIDS drug development and treatment (3 papers). Sanne B. Jensen is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and HIV/AIDS drug development and treatment (3 papers). Sanne B. Jensen collaborates with scholars based in Denmark and United States. Sanne B. Jensen's co-authors include Judith M. Gottwein, Jens Bukh, Yi‐Ping Li, Santseharay Ramírez, Daryl Humes, Robert H. Purcell, Stéphanie B. N. Serre, Lubna Ghanem, Lotte S. Mikkelsen and Troels K. H. Scheel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Hepatology.

In The Last Decade

Sanne B. Jensen

8 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanne B. Jensen Denmark 8 312 289 91 60 26 9 341
Lubna Ghanem Denmark 7 317 1.0× 284 1.0× 93 1.0× 50 0.8× 27 1.0× 7 344
Sabrina Bagaglio Italy 13 374 1.2× 343 1.2× 152 1.7× 12 0.2× 45 1.7× 50 494
Susan Purdy United States 8 518 1.7× 422 1.5× 174 1.9× 39 0.7× 54 2.1× 9 578
Ellen Xia United States 9 271 0.9× 205 0.7× 167 1.8× 35 0.6× 24 0.9× 13 296
Katrien Vermeiren Sweden 4 285 0.9× 222 0.8× 170 1.9× 29 0.5× 40 1.5× 5 346
Stéphanie Dincq Belgium 4 154 0.5× 143 0.5× 33 0.4× 33 0.6× 20 0.8× 7 192
Frédéric Delouvroy Sweden 4 141 0.5× 97 0.3× 74 0.8× 24 0.4× 50 1.9× 5 210
Margaret Gartland United States 9 148 0.5× 156 0.5× 201 2.2× 21 0.3× 82 3.2× 15 404
Betty Peng United States 9 268 0.9× 241 0.8× 130 1.4× 27 0.5× 38 1.5× 13 294
Elizabeth M. Amphlett United Kingdom 6 215 0.7× 102 0.4× 63 0.7× 41 0.7× 127 4.9× 8 295

Countries citing papers authored by Sanne B. Jensen

Since Specialization
Citations

This map shows the geographic impact of Sanne B. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanne B. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanne B. Jensen more than expected).

Fields of papers citing papers by Sanne B. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanne B. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanne B. Jensen. The network helps show where Sanne B. Jensen may publish in the future.

Co-authorship network of co-authors of Sanne B. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Sanne B. Jensen. A scholar is included among the top collaborators of Sanne B. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanne B. Jensen. Sanne B. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pham, Long V., Sanne B. Jensen, Ulrik Fahnøe, et al.. (2018). HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape. Journal of Hepatology. 70(3). 388–397. 32 indexed citations
2.
Serre, Stéphanie B. N., Sanne B. Jensen, Lubna Ghanem, et al.. (2016). Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle. Antimicrobial Agents and Chemotherapy. 60(6). 3563–3578. 23 indexed citations
3.
Jensen, Sanne B., Stéphanie B. N. Serre, Daryl Humes, et al.. (2015). Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance. Antimicrobial Agents and Chemotherapy. 59(12). 7426–7436. 35 indexed citations
5.
Li, Yi‐Ping, Santseharay Ramírez, Daryl Humes, et al.. (2013). Differential Sensitivity of 5′UTR-NS5A Recombinants of Hepatitis C Virus Genotypes 1−6 to Protease and NS5A Inhibitors. Gastroenterology. 146(3). 812–821.e4. 52 indexed citations
7.
Gottwein, Judith M., Sanne B. Jensen, Stéphanie B. N. Serre, et al.. (2013). Adapted J6/JFH1-Based Hepatitis C Virus Recombinants with Genotype-Specific NS4A Show Similar Efficacies against Lead Protease Inhibitors, Alpha Interferon, and a Putative NS4A Inhibitor. Antimicrobial Agents and Chemotherapy. 57(12). 6034–6049. 15 indexed citations
8.
Gottwein, Judith M., Sanne B. Jensen, Yi‐Ping Li, et al.. (2012). Combination Treatment with Hepatitis C Virus Protease and NS5A Inhibitors Is Effective against Recombinant Genotype 1a, 2a, and 3a Viruses. Antimicrobial Agents and Chemotherapy. 57(3). 1291–1303. 32 indexed citations
9.
Li, Yi‐Ping, Santseharay Ramírez, Sanne B. Jensen, et al.. (2012). Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proceedings of the National Academy of Sciences. 109(48). 19757–19762. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026